Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Start 7-day free trial → Log in

Test Product

Small molecule · developed by Amneal Ireland

Phase 3 Most advanced trial (none active)

AMRX Developer

1 Registered trials

What is Test Product?

Test Product is beclomethasone dipropionate, delivered as an inhalation aerosol at 40 mcg. It is studied in asthma.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type: Small molecule
Therapy area: Respiratory
Developer: Amneal Ireland Limited (AMRX)
FDA status: Investigational, not approved in the US. Most advanced trial: Phase 3

🧪 Clinical trials

Trial	Phase	Condition	Status	Sponsor
NCT03562949	Phase 3	Asthma	Terminated	AMRX

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Asthma

More from Amneal Ireland

KSHN001126 Phase 1

Sources

ClinicalTrials.gov NCT03562949

Updated Oct 11, 2026. Something wrong or missing? Report it on the AMRX page.

Follow AMRX, the company behind Test Product

See AMRX's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

AMRX catalysts and pipeline →

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z